Table 1

Baseline demographic and clinical characteristics of SIVD-WMH patients and controls
SIVD-WMH patients (n = 17) Control subjects (n = 17)
Age (yrs ) 74.6 ± 8 74.4 ± 8
Sex ratio (m/f) 9/8 9/8
WMH score (Fazekas) 3 ± 0 1 ± 1
MMSE score 22 ± 5 28.5 ± 1
RAVLT immediate recall score 10 ± 12 32 ± 14
RAVLT delayed recall score 1 ± 2 6 ± 4
Trailmaking A (sec) 168 ± 116 45 ± 13
Trailmaking B (sec) 653 ± 320 105 ± 42
Verbal fluency (number / 60 sec) 20 ± 5.7 10 ± 4.8

Values are expressed as mean ± SD unless otherwise indicated.

van Straaten et al.

van Straaten et al. BMC Neuroscience 2012 13:85   doi:10.1186/1471-2202-13-85

Open Data